Anavex Life Sciences(DE:12X1)
€0.76-0.05 (-6.15%)
DE:12X1
Anavex Life Sciences ownership
€0.76
At close:-0.05 (-6.15%)
Anavex Life Sciences (12X1) Ownership - Who Owns Anavex Life Sciences?
2 Followers
Anavex Life Sciences (12X1) Ownership Overview
- 1.66% Insiders
- 10.55% Mutual Funds
- 10.02% Other Institutional Investors
- 12.08% ETFs
- 65.69% Public Companies and Individual Investors
The ownership structure of Anavex Life Sciences (DE:12X1) stock is a mix of institutional, retail, and individual investors. Approximately 32.65% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders, and 65.69% is owned by Public Companies and Individual Investors.
The ownership structure of Anavex Life Sciences (DE:12X1) stock is a mix of institutional, retail, and individual investors. Approximately 32.65% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders, and 65.69% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 8,144,147 | Institution | 8.79% | 6,849,228 |
| Vanguard | 4,906,152 | Institution | 5.29% | 4,126,074 |
| Ishares | 4,826,923 | Institution | 5.21% | 4,059,442 |
| Vanguard Index Funds | 3,966,953 | Institution | 4.28% | 3,336,207 |
| Federated Hermes Mdt Series | 2,045,098 | Institution | 2.21% | 1,719,927 |
| Christopher Missling | 1,510,165 | Insider | 1.63% | 1,270,049 |
| Fidelity Salem Street Trust | 1,129,534 | Institution | 1.22% | 949,938 |
| Fidelity Concord Street Trust | 838,374 | Institution | 0.90% | 705,073 |
| Vanguard Scottsdale Funds | 622,810 | Institution | 0.67% | 523,783 |
| Schwab | 563,695 | Institution | 0.61% | 474,067 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,966,953 | Institution | 4.28% | 3,336,207 |
| Federated Hermes Mdt Series | 2,045,098 | Institution | 2.21% | 1,719,927 |
| Fidelity Salem Street Trust | 1,129,534 | Institution | 1.22% | 949,938 |
| Fidelity Concord Street Trust | 838,374 | Institution | 0.90% | 705,073 |
| Vanguard Scottsdale Funds | 622,810 | Institution | 0.67% | 523,783 |
| Tiaa-cref Funds | 312,085 | Institution | 0.34% | 262,463 |
| Vanguard World Fund | 270,423 | Institution | 0.29% | 227,426 |
| Schwab Capital Trust | 224,867 | Institution | 0.24% | 189,113 |
| Bridgeway Funds, Inc. | 123,000 | Institution | 0.13% | 103,443 |
| Vanguard Valley Forge Funds | 48,976 | Institution | 0.05% | 41,189 |
FAQ
Who Owns Anavex Life Sciences (DE:12X1)?
According to the latest TipRanks data, approximately 32.65% of the company's stock is held by institutional investors, 1.66% is held by insiders, and 65.69% is held by public companies and individual investors.
What percentage of Anavex Life Sciences (DE:12X1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.65% of Anavex Life Sciences (DE:12X1) stock is held by institutional investors: 10.55% by mutual funds, 12.08% by ETFs and 10.02% by other institutional investors.
What percentage of Anavex Life Sciences (DE:12X1) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.69% of Anavex Life Sciences (DE:12X1) stock is held by public companies and individual investors.
Who owns the most shares of Anavex Life Sciences (DE:12X1)?
BlackRock, Inc. owns the most shares of Anavex Life Sciences (DE:12X1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
